Study Objectives: From 2019–2023, the United States Food and Drug Administration has
cleared 9 novel obstructive sleep apnea-detecting wearables for home sleep apnea testing …

Nocturnal sympathetic overdrive is an early indicator of cardiovascular (CV) disease,
emphasizing the importance of reliable remote patient monitoring (RPM) for autonomic …

BACKGROUND: Obstructive sleep apnea is associated with increased blood pressure (BP).
Obstructive sleep apnea treatment reduces BP with substantial variability, not explained by …

Obstructive sleep apnea (OSA) affects almost a billion people worldwide and is associated
with a myriad of adverse health outcomes. Among the most prevalent and morbid are …

Background Over the past three decades, our understanding of sleep apnea in women has
advanced, revealing disparities in pathophysiology, diagnosis, and treatment compared to …

Together with (physical and mental) exercise, diet, and social activities, sleep is a key health
behavior that occupies one third of our lives, yet remains neglected. In the first part of this …

High blood pressure (BP) is a common disease and is associated with many chronic
diseases. Measuring BP is essential for the treatment and management of many diseases …

The rail industry in Australia screens workers for probable obstructive sleep apnea (OSA)
due to known safety risks. However, existing criteria to trigger screening only identify a small …

Obstructive sleep apnea (OSA) is a common condition that is increasing in prevalence
worldwide. Untreated OSA has a negative impact on health-related quality of life and is an …

Sleep-wake disorders (SWD) are acknowledged risk factors for both ischemic stroke and
poor cardiovascular and functional outcome after stroke. SWD are frequent following stroke …